Mutations in two-component signaling systems drive experimental evolution of tigecycline and colistin resistance in <i>Acinetobacter baumannii</i>

James E. Kent(Sanford Burnham Prebys Medical Discovery Institute), Andrei L. Osterman(Sanford Burnham Prebys Medical Discovery Institute), Andreas Haldimann(Purdue University West Lafayette), Séverine Louvel(Roche (Switzerland)), Claudia Zampaloni(Roche (Switzerland)), Nicholas C. Wong(Monash University), Jaime E. Zlamal(Roche (Switzerland)), Maarten Vercruysse(Roche (Switzerland)), Semen A. Leyn(Agilent Technologies (United States)), M. Aizin(Sanford Burnham Prebys Medical Discovery Institute), Marinela L. Elane(Sanford Burnham Prebys Medical Discovery Institute)
Antimicrobial Agents and Chemotherapy
October 29, 2025
Cited by 1


Related Papers